12/21/20 Victorian Cancer Biobank (VCB) profile uploaded

VCB is one of the largest multi-center collection facilities of its kind in the world, collecting tissue and blood from donors at 26 public & private hospitals in metropolitan Melbourne. VCB has an open-door policy to public and private investigators or companies that have an ethically approved research project. It is customer-focused with an archival collection of >400,000 biospecimens in various storage formats and can support prospective collections.

Victorian Cancer Biobank (VCB) (Australia)

Database Contact Data

Wayne Ng, PhD 
General Manager
Victorian Cancer Biobank
615 St. Kilda Rd
Melbourne, Victoria 3004 
AUSTRALIA
Phone: +61 3 9514 6179
Email: Wayne.Ng@cancervic.org.au

Alternate Contact

1. Enquiries
Project Manager
Victorian Cancer Biobank
615 St Kilda Rd
Melbourne, Victoria 3004
AUSTRALIA
Phone: +61 3 9514 6186
Email: VCBEnquiries@cancervic.org.au

2. If you cannot reach the database manager, you may contact the Biobank by completing the contact form at: https://viccancerbiobank.org.au/services/enquire

References of Studies Using/Describing Database

1. Joyce R, Pascual R, Heitink L, Capaldo BD, Vaillant F, Christie M, Tsai M, Surgenor E, Anttila CJ, Rajasekhar P, Jackling FC. Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature Cell Biology. 2024 Jan 12:1-5.

2. Li R, Liu S, Yeo K, Edwards S, Li MY, Santos R, Kianpour Rad S, Wu F, Maddern G, Young J, Tomita Y. Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease. medRxiv. 2024:2024-03.

3. Tan T, Mouradov D, Lee M, Gard G, Hirokawa Y, Li S, Lin C, Li F, Luo H, Wu K, Palmieri M. Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer. Cell Reports Medicine. 2023 Dec 19;4(12).

4. Lam GT, Sorvina A, Martini C, Prabhakaran S, Ung BS, Lazniewska J, Moore CR, Beck AR, Hopkins AM, Johnson IR, Caruso MC. Altered endosomal-lysosomal biogenesis in melanoma. Neoplasia. 2023 Sep 1;43:100924.

5. Weeden CE, Gayevskiy V, Marceaux C, Batey D, Tan T, Yokote K, Ribera NT, Clatch A, Christo S, Teh CE, Mitchell AJ. Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer. Cancer Cell. 2023 May 8;41(5):837-52.

6. Leong TL, Aloe C, Aujla S, Wang H, Gayevskiy V, Asselin-Labat ML, Gray LA, Steinfort D, Bozinovski S. Heterogeneity of tumour mutational burden in metastatic NSCLC demonstrated by endobronchial ultrasound sampling. Frontiers in Oncology. 2023 Mar 13;13:1150349.

7. Cain SA, Pope B, Mangiola S, Mantamadiotis T, Drummond KJ. Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression. BMC cancer. 2023 Mar 7;23(1):216.

8. Coombes C, Horikawa K, Jain S, Jiang S, Lim JH, Saxena K, Shadbolt B, Smyth L, Tobin J, Talaulikar D. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis. Pathology. 2023 Feb 1;55(1):104-12.

9. Shewell LK, Day CJ, Hippolite T, De Bisscop X, Paton JC, Paton AW, Jennings MP. Serum Neu5Gc biomarkers are elevated in primary cutaneous melanoma. Biochem Biophys Res Commun. 2023 Jan 29;642:162-166.

10. Boys, Emma, Jia Liu, Zhaoxiang Cai, Zainab Noor, Karen L. Mackenzie, Adel Aref, Erin Sykes et al. Pan-cancer diagnostic proteomic signature of tissue-of-origin (TOO) using data-independent acquisition mass spectrometry (DIA-MS) from 1289 human tissue samples. Journal of Clinical Oncology. 2023;41(16): 3120-3120.

Subscribe to